To read the full story, subscribe or sign in.

International Fluid Academy Scientific Meeting: Are SOC IV fluid guidelines drowning patients in salt water?

Dec. 2, 2014

By Ronald Trahan

No Comments

BioWorld MedTech

Today's news in brief

BioWorld

BioWorld briefs for Dec. 12, 2024.

Today's news in brief

BioWorld MedTech

BioWorld MedTech briefs for December 12, 2024.

Second insulin receptor offers new therapeutic avenues

BioWorld Science

Investigators at the Helmholtz Institute have shown that inceptor, an inhibitor of the insulin signaling pathway, acted by binding insulin and targeting it for...

KITE-753, a rapid manufactured CAR T therapy with superior antitumor efficacy and enhanced expansion in vivo

BioWorld Science

In a presentation at the recent American Society of Hematology meeting in San Diego, Kite Pharma Inc. reported preclinical data for KITE-753, an autologous rapid...

Keros stock wilts as it halts two dosing arms in hypertension study

BioWorld

After Keros Therapeutics Inc.’s voluntary halt of dosing in two arms of its phase II study in pulmonary arterial hypertension, the company’s stock crumpled after...

Upgrade your daily dose of biopharma and medtech news

International Fluid Academy Scientific Meeting: Are SOC IV fluid guidelines drowning patients in salt water?